UA90290C2 - Spiroketal derivatives and use thereof as diabetic medicine - Google Patents

Spiroketal derivatives and use thereof as diabetic medicine

Info

Publication number
UA90290C2
UA90290C2 UAA200708661A UAA200708661A UA90290C2 UA 90290 C2 UA90290 C2 UA 90290C2 UA A200708661 A UAA200708661 A UA A200708661A UA A200708661 A UAA200708661 A UA A200708661A UA 90290 C2 UA90290 C2 UA 90290C2
Authority
UA
Ukraine
Prior art keywords
optionally substituted
group
compound
disclosed
calkyl
Prior art date
Application number
UAA200708661A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Такамицу Кобаяси
Цутому Сато
Масахиро Нисимото
Original Assignee
Чугаи Сейяку Кабусики Кайся
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чугаи Сейяку Кабусики Кайся filed Critical Чугаи Сейяку Кабусики Кайся
Publication of UA90290C2 publication Critical patent/UA90290C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed is a compound represented by the following formula (I), wherein R, R, Rand Rindependently represent a hydrogen atom, an optionally substituted C-Calkyl group, an optionally substituted C-Caralkyl group or -C(=O)Rx; Rx represents an optionally substituted C-Calkyl group, an optionally substituted aryl group, an optionally substituted heteroaryl group, an optionally substituted C-Calkoxy group or -NReRf; Arrepresents an optionally substituted aromatic hydrocarbon ring or an optionally 1-substituted aromatic heterocycle; Q represents -(CH)-(L)- or -(L)-(CH)-; m represents an integer of 0-2; n represents 1 or 2; p represents 0 or 1; L represents -O-, -S- or -NR -; and A represents an optionally substituted aryl group or an optionally substituted heteroaryl group. Also disclosed are a prodrug of such a compound, a pharmaceutically acceptable salt thereof, a pharmaceutical product or pharmaceutical composition containing such a compound, and the like.
UAA200708661A 2005-01-28 2006-01-27 Spiroketal derivatives and use thereof as diabetic medicine UA90290C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005020901 2005-01-28

Publications (1)

Publication Number Publication Date
UA90290C2 true UA90290C2 (en) 2010-04-26

Family

ID=39043036

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200708661A UA90290C2 (en) 2005-01-28 2006-01-27 Spiroketal derivatives and use thereof as diabetic medicine

Country Status (3)

Country Link
CN (1) CN101111508B (en)
UA (1) UA90290C2 (en)
ZA (1) ZA200706022B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5711669B2 (en) * 2009-12-18 2015-05-07 中外製薬株式会社 Method for producing spiroketal derivative
CN106317068A (en) * 2015-06-23 2017-01-11 中国科学院上海药物研究所 C, O-spiro aryl glycoside compound and preparation and application thereof
CN106892929B (en) * 2015-12-17 2020-01-14 上海艾力斯医药科技有限公司 Spiroketal derivative and preparation method and application thereof
CN115873048A (en) * 2021-09-26 2023-03-31 南京华威医药科技集团有限公司 Preparation method of tobermycin oxidized impurities

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12000002657B1 (en) * 1999-10-12 2006-02-21 Bristol Myers Squibb Co C-aryl glucoside SGLT2 inhibitors
SK287183B6 (en) * 2000-03-17 2010-02-08 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives and the use of them

Also Published As

Publication number Publication date
ZA200706022B (en) 2008-11-26
CN101111508B (en) 2011-03-30
CN101111508A (en) 2008-01-23

Similar Documents

Publication Publication Date Title
HK1111999A1 (en) Spiroketal derivative and use thereof as diabetic medicine
WO2003011880A1 (en) Glucopyrano syloxybenzyl benzene derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
TW200606129A (en) Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
TW200745034A (en) New compounds
TW200716528A (en) Cyclopropanecarboxamide derivatives
EP1775289A4 (en) Novel imidazolidine derivatives
EP1609798A4 (en) Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
MY149622A (en) Pyrazoles as 11-beta-hsd-1
EP1637521A4 (en) Novel tricyclic heterocycle compound
MX2009003927A (en) Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes.
EP1679309A4 (en) Antistress drug and medical use thereof
TW200643013A (en) Pyrazoles
WO2009107850A3 (en) Fused heterocyclic derivative and use thereof
HK1125358A1 (en) Substituted cyclohexylmethyl derivatives
TW200626553A (en) Novel compounds
PL1758852T3 (en) Substituted cyclopentene compounds
AP1522A (en) Compounds having hypolipedemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them.
UA90290C2 (en) Spiroketal derivatives and use thereof as diabetic medicine
EA200870223A1 (en) DERIVATIVES OF BENZOIZOINDOL FOR THE TREATMENT OF PAIN
WO2008102888A1 (en) Novel pseudoglycolipid and use thereof
EP1908752A4 (en) Novel 2-quinolone derivative
WO2009019721A3 (en) Quercetin derivatives as anti-cancer agents
UA81610C2 (en) Isoquinoline derivatives, process for their preparation and pharmaceutical composition containing thereof
YU83403A (en) Use of pyridoindolone derivatives for preparing medicines